PCH-2 regulates Caenorhabditis elegans lifespan.

Area of Science:

• Genetics
• Aging Research
• Cell Biology

Background:

• Insulin/IGF-1 and TOR pathways, along with metabolic genes, are known lifespan regulators in C. elegans.
• The TRIP13 gene and its C. elegans homolog pch-2 are primarily studied for roles in cell division (mitosis and meiosis).
• No prior studies have linked pch-2 or TRIP13 to lifespan regulation.

Purpose of the Study:

• To investigate the potential role of pch-2/TRIP13 in lifespan determination and stress resistance.
• To elucidate the molecular mechanisms underlying pch-2's function in longevity.

Main Methods:

• Overexpression of TRIP13 in human fibroblasts.
• Overexpression and RNA interference (RNAi) of pch-2 in C. elegans.
• Assessing stress resistance (UV, oxidative stress) in human cells and worms.
• Genetic epistasis analysis in C. elegans.

Main Results:

• TRIP13 overexpression confers resistance to UV and oxidative stress in human fibroblasts.
• pch-2 overexpression extends C. elegans lifespan and enhances survival under stress.
• Reducing pch-2 expression via RNAi shortens worm lifespan.
• Epistasis analysis reveals pch-2's longevity mechanism involves the sirtuin family.

Conclusions:

• The pch-2 gene plays a novel role in regulating lifespan and stress resistance in C. elegans.
• pch-2 functions as a chromatin regulator in longevity pathways, potentially through sirtuin interactions.
• TRIP13 may represent a conserved target for interventions aimed at enhancing stress resilience and longevity.